{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "November 2018: 55-year-old male presented with cough with sputum, chest distress, and breathlessness. CT scan revealed a lung mass in the lower left lobe. Brain MRI revealed brain metastases in the left frontal lobe and insula.",
        "timestamp": "2018-11",
        "clinical_data": {
          "HPI": [
            {
              "summary": "55-year-old male presented with cough with sputum, chest distress, and breathlessness.",
              "onset": "November 2018",
              "associated_symptoms": [
                "C0010200",
                "C0008031",
                "C0020678"
              ]
            }
          ],
          "imaging": [
            {
              "type": "Lung mass",
              "body_part": "Lower left lobe",
              "modality": "CT",
              "date": "2018-11",
              "finding": "Lung mass in the lower left lobe"
            },
            {
              "type": "Brain metastases",
              "body_part": "Left frontal lobe and insula",
              "modality": "MRI",
              "date": "2018-11",
              "finding": "Brain metastases in the left frontal lobe and insula"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "November 19, 2018: Percutaneous lung biopsy confirmed adenocarcinoma. Clinically diagnosed with stage IVa lung adenocarcinoma (cT1cN1M1b) with an EGFR 19del mutation detected through NGS.",
        "timestamp": "2018-11-19",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0002827",
              "label": "Adenocarcinoma",
              "status": "active",
              "onset_date": "2018-11-19"
            },
            {
              "code": "C0024117",
              "label": "Lung Adenocarcinoma",
              "status": "active",
              "onset_date": "2018-11-19"
            }
          ],
          "procedures": [
            {
              "name": "C0162645",
              "approach": "percutaneous",
              "date": "2018-11-19",
              "location": "lung",
              "performed_by": null,
              "outcome": null
            }
          ],
          "labs": [
            {
              "test": "EGFR 19del mutation",
              "value": "detected",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": "2018-11-19"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "December 3, 2018: Gefitinib (250 mg, once a day) was administered. Variant allele frequencies (VAFs) of the detected EGFR 19del mutation were 19.6%.",
        "timestamp": "2018-12-03",
        "clinical_data": {
          "medications": [
            {
              "drug": "Gefitinib",
              "dosage": "250 mg",
              "frequency": "once a day",
              "modality": "oral",
              "start_date": "2018-12-03"
            }
          ],
          "labs": [
            {
              "test": "Variant allele frequencies",
              "value": "19.6%",
              "unit": "%",
              "timestamp": "2018-12-03"
            }
          ],
          "diagnoses": [
            {
              "code": "EGFR 19del",
              "label": "EGFR 19del mutation",
              "status": "active",
              "onset_date": "2018-12-03"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "December 31st 2018: Chest CT scans showed significant reduction in the original lung mass. Brain metastases almost disappeared. Partial remission (PR) and complete remission (CR) were achieved respectively.",
        "timestamp": "2018-12-31",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "significant reduction in the original lung mass",
              "date": "2018-12-31"
            },
            {
              "type": "Computed tomography",
              "body_part": "Brain",
              "modality": "CT",
              "finding": "Brain metastases almost disappeared",
              "date": "2018-12-31"
            }
          ],
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung mass",
              "status": "resolved",
              "onset_date": null
            },
            {
              "code": "C79.31",
              "label": "Brain metastases",
              "status": "resolved",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "January 2019 - June 2019: Received 6 cycles of PC regimen (pemetrexed 1 g and carboplatin 500 mg).",
        "timestamp": "2019-01/2019-06",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974732",
              "dosage": "1 g",
              "frequency": "every cycle",
              "modality": "IV",
              "start_date": "2019-01",
              "end_date": "2019-06",
              "indication": "Neoplasm"
            },
            {
              "drug": "C0007268",
              "dosage": "500 mg",
              "frequency": "every cycle",
              "modality": "IV",
              "start_date": "2019-01",
              "end_date": "2019-06",
              "indication": "Neoplasm"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "July 2019 - November 2019: Maintained with single pemetrexed (1 g) chemotherapy for 5 cycles. Regular follow-up shows partial remission (PR).",
        "timestamp": "2019-07/2019-11",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0070709",
              "dosage": "1 g",
              "frequency": "every 3 weeks",
              "modality": "IV",
              "start_date": "2019-07",
              "end_date": "2019-11",
              "indication": "cancer"
            }
          ],
          "diagnoses": [
            {
              "code": "C0030705",
              "label": "Partial remission",
              "status": "active",
              "onset_date": "2019-11"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "December 3, 2019: Brain MRI revealed a new craniocerebral metastasis.",
        "timestamp": "2019-12-03",
        "clinical_data": {
          "imaging": [
            {
              "type": "Craniocerebral MRI",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "New craniocerebral metastasis",
              "date": "2019-12-03"
            }
          ],
          "diagnoses": [
            {
              "code": "C0206324",
              "label": "metastasis",
              "status": "active",
              "onset_date": "2019-12-03"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "December 18, 2019 to December 31, 2019: Administered gefitinib continually (no EGFR mutation detected) combined with brain intensity modulated radiation therapy (IMRT) (DT 3000cGy/10F whole brain).",
        "timestamp": "2019-12-1",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974086",
              "dosage": null,
              "frequency": "continually",
              "modality": null,
              "start_date": "2019-12-18",
              "end_date": "2019-12-31",
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C1704453",
              "approach": null,
              "date": "2019-12-18",
              "location": "brain",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "From initial presentation with cough, chest distress, and breathlessness, the patient underwent a percutaneous lung biopsy which confirmed adenocarcinoma. NGS revealed EGFR 19del mutation, leading to a diagnosis of stage IVa lung adenocarcinoma (cT1cN1M1b)."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Following diagnosis of stage IVa lung adenocarcinoma with EGFR 19del mutation, Gefitinib (250 mg, once a day) was initiated.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0085753"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2018-12-03"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Following Gefitinib treatment, chest CT scans showed significant reduction in the original lung mass and brain metastases almost disappeared, achieving partial remission (PR) and complete remission (CR) respectively.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "C0009425",
            "C0034091"
          ],
          "change_type": "resolution",
          "target_domain": "imaging",
          "timestamp": "2018-12-31"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Following initial response to Gefitinib, the patient received 6 cycles of PC regimen (pemetrexed 1 g and carboplatin 500 mg).",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974732",
            "C0007268"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2019-01"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "After completing 6 cycles of PC regimen, the patient was maintained with single agent pemetrexed (1 g) chemotherapy for 5 cycles, with regular follow-up showing partial remission (PR).",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0070709"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2019-07"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Despite maintenance therapy with pemetrexed, a brain MRI revealed a new craniocerebral metastasis.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [
            "C0206324"
          ],
          "change_type": "progression",
          "target_domain": "imaging",
          "timestamp": "2019-12-03"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Following the detection of a new craniocerebral metastasis, the patient was administered gefitinib continually (no EGFR mutation detected) combined with brain intensity modulated radiation therapy (IMRT) (DT 3000cGy/10F whole brain).",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C1704"
          ]
        }
      }
    }
  ]
}